6E59
Crystal structure of the human NK1 tachykinin receptor
Summary for 6E59
| Entry DOI | 10.2210/pdb6e59/pdb |
| Descriptor | Substance-P receptor, GlgA glycogen synthase, Substance-P receptor chimera, 1-(4-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-1H-1,2,3-triazol-5-yl)-N,N-dimethylmethanamine (2 entities in total) |
| Functional Keywords | g protein-coupled receptor fusion protein, signaling protein |
| Biological source | Homo sapiens (Human) More |
| Total number of polymer chains | 1 |
| Total formula weight | 62449.70 |
| Authors | Yin, J.,Clark, L.,Chapman, K.,Shao, Z.,Borek, D.,Xu, Q.,Wang, J.,Rosenbaum, D.M. (deposition date: 2018-07-19, release date: 2018-12-12, Last modification date: 2023-10-11) |
| Primary citation | Yin, J.,Chapman, K.,Clark, L.D.,Shao, Z.,Borek, D.,Xu, Q.,Wang, J.,Rosenbaum, D.M. Crystal structure of the human NK1tachykinin receptor. Proc. Natl. Acad. Sci. U.S.A., 115:13264-13269, 2018 Cited by PubMed Abstract: The NK tachykinin G-protein-coupled receptor (GPCR) binds substance P, the first neuropeptide to be discovered in mammals. Through activation of NKR, substance P modulates a wide variety of physiological and disease processes including nociception, inflammation, and depression. Human NKR (hNKR) modulators have shown promise in clinical trials for migraine, depression, and emesis. However, the only currently approved drugs targeting hNKR are inhibitors for chemotherapy-induced nausea and vomiting (CINV). To better understand the molecular basis of ligand recognition and selectivity, we solved the crystal structure of hNKR bound to the inhibitor L760735, a close analog of the drug aprepitant. Our crystal structure reveals the basis for antagonist interaction in the deep and narrow orthosteric pocket of the receptor. We used our structure as a template for computational docking and molecular-dynamics simulations to dissect the energetic importance of binding pocket interactions and model the binding of aprepitant. The structure of hNKR is a valuable tool in the further development of tachykinin receptor modulators for multiple clinical applications. PubMed: 30538204DOI: 10.1073/pnas.1812717115 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (3.4 Å) |
Structure validation
Download full validation report
